A Phase 3, Open-Label, Single-Arm, Multicenter Study to Evaluate Ravulizumab Administered Intravenously in Pediatric Patients With Anti-Acetylcholine Receptor Antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis (gMG) (P7-6.014)
Year: 2025
Type: article
Study design: Clinical Trial
Source: Neurology
Authors: Gwendolyn Niebler, Sarbesh Pandeya, Sourish Chakravarty, Glen Frick
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409222339